Docoh
Loading...

20 results

Filter options loading...
Top filers
Top filing types
Recent filing years
DEF 14A
PRPO Precipio Inc
29 Apr 21
Definitive proxy
4:31pm
. Andrews is also a member of the Board of Governors of CancerLinQ LLC, a wholly-owned non-profit subsidiary of the American Society of Clinical Oncology
8-K
PRPO Precipio Inc
3 Mar 21
Mr. Richard Sandberg is appointed Chairman of Precipio’s Board of Directors
4:30pm
ImmunoTec. Mr. Andrews is also a member of the Board of Governors of CancerLinQ LLC, a wholly-owned non-profit subsidiary of the American Society
10-Q
2020 Q3
PRPO Precipio Inc
13 Nov 20
Quarterly report
4:01pm
are important elements of controlling the pandemic, antibody testing is key to enabling society to return to full functionality. The antibody test for IgM
10-Q
2020 Q2
PRPO Precipio Inc
13 Aug 20
Quarterly report
3:07pm
testing is key to enabling society to return to full functionality. The antibody test for IgM and IgG detects the body's immune response to the infection
10-K
2015 FY
PRPO Precipio Inc
13 Apr 16
Annual report
8:00pm
the quality and performance of MX-ICP. On May 29, 2015, at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, we announced the launch
10-Q
2015 Q2
PRPO Precipio Inc
13 Aug 15
Quarterly report
8:00pm
and performance of MX-ICP. On May 29, 2015, at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, we announced the launch of our
8-K
EX-99.1
PRPO Precipio Inc
13 Jan 15
Regulation FD Disclosure
7:00pm
/ surveillance North American Oncology Market Sources: World Health Organization (WHO), American Cancer Society, Centers for Disease Control (CDC) NSCLC
8-K
EX-99.1
PRPO Precipio Inc
10 Dec 14
Regulation FD Disclosure
7:00pm
market in the next 3 - 6 years Sources: World Health Organization (WHO), American Cancer Society, Centers for Disease Control (CDC) CRC 15% NSCLC 20
10-Q
2014 Q2
PRPO Precipio Inc
7 Aug 14
Quarterly report
8:00pm
scientific posters on ICE COLD-PCR at our booth at the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting in late May 2014. An important
10-K
2013 FY
PRPO Precipio Inc
26 Mar 14
Annual report
8:00pm
, Amgen presented results of a predefined-retrospective subset analysis of a global, multicenter, randomized Phase 3 study at the American Society
10-Q
2013 Q3
PRPO Precipio Inc
13 Nov 13
Quarterly report
7:00pm
analysis of a global, multicenter, randomized Phase 3 study at the American Society of Clinical Oncology (ASCO) 2013 Annual Meeting. The RAS mutations
10-Q
2013 Q2
PRPO Precipio Inc
7 Aug 13
Quarterly report
8:00pm
-retrospective subset analysis of a global, multicenter, randomized Phase 3 study at the American Society of Clinical Oncology (ASCO) 2013 Annual Meeting
10-Q
2012 Q1
PRPO Precipio Inc
8 May 12
Quarterly report
8:00pm
of existing tests and the launch of new products into the marketplace. In May, the Heart Rhythm Society issued new diagnostic guidelines supporting
10-K
2011 FY
PRPO Precipio Inc
13 Mar 12
Annual report
8:00pm
of new products into the marketplace. In May, the Heart Rhythm Society issued new diagnostic guidelines supporting the use of some of our key cardiac tests
10-Q
2011 Q3
PRPO Precipio Inc
9 Nov 11
Quarterly report
7:00pm
use of existing tests and the launch of new products into the marketplace. In May, the Heart Rhythm Society issued new diagnostic guidelines supporting
8-K
EX-99.1
PRPO Precipio Inc
6 Oct 11
Regulation FD Disclosure
8:00pm
with Dana Farber Cancer Institute and presented at the American Association of Cancer Research and the American Society of Clinical Oncology meetings
8-K
EX-99.1
PRPO Precipio Inc
29 Nov 10
Entry into a Material Definitive Agreement
7:00pm
280 million patients; established academic and medical society guidelines, as well as the Heart Failure Society of America guidelines, that include
10-K
2003 FY
PRPO Precipio Inc
29 Mar 04
Annual report
7:00pm
in several presentations at the American Society of Hematology annual meeting, pursuant to Items 5 and 7 of Form 8-K. The Registrant filed a Report
8-K
EX-99.1
PRPO Precipio Inc
3 Dec 03
Other events
7:00pm
at the American Society of Hematology (ASH) annual meeting, Dec. 6-8 in San Diego, Calif. Two of these presentations involve the analysis of genes that have … -782-2840/ /Web site: http://www.transgenomic.com / (TBIO) CO: Transgenomic, Inc.; American Society of Hematology ST: Nebraska, California IN: MTC BIO SU:
8-K
  • 1